Drugmakers are up in arms over a new program letting Medicare negotiate lower prices for a handful of medicines. Andrew Perez, a Senior Editor and Reporter at The Lever, discusses his new article, Big Pharma’s American Con, in which he reveals that the drugs up for negotiation are being sold for significantly less in other countries, leaving Americans to pay up to 1,000% more for the same drug.

---